If you asked 100 individuals about psychedelics, chances are that you will receive 100 different opinions on the subject, most of them based on what the person has heard about these substances, their own personal experiences decades ago or even what the person has seen in sensationalized movies on the subject. So, where does one turn for unbiased and reliable information about psychedelics? While talking to an online media outlet recently, Dr. Domenick J. Sporteli, a specialist in psychopharmacology and human behavior, as well as a board-certified neurologist and psychiatrist, answered some of the most nagging questions about psychedelics. We captured the excerpts of that discussion.
Is there ample evidence in support of psychedelic therapy?
While MDMA, psilocybin, ketamine, DMT, LSD, and peyote are all categorized as psychedelics, each one of them has a different mechanism through which it works and they each induce…
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]
PsychedelicNewsWire is part of the InvestorBrandNetwork.